AXIN1
Axin-1 is a protein that in humans is encoded by the AXIN1 gene.[1]
This gene encodes a cytoplasmic protein which contains a regulation of G-protein signaling (RGS) domain and a dishevelled and axin (DIX) domain. The encoded protein interacts with adenomatosis polyposis coli, catenin (cadherin-associated protein), beta 1, 88kDa, glycogen synthase kinase 3 beta, protein phosphate 2, and itself. This protein functions as a negative regulator of the wingless-type MMTV integration site family, member 1 (WNT) signaling pathway and can induce apoptosis. The crystal structure of a portion of this protein, alone and in a complex with other proteins, has been resolved. Mutations in this gene have been associated with hepatocellular carcinoma, hepatoblastomas, ovarian endometriod adenocarcinomas, and medullablastomas. Two transcript variants encoding distinct isoforms have been identified for this gene.[2]
Interactions
AXIN1 has been shown to interact with Beta-catenin,[3][4] GSK3B,[3][5] TSC2,[5] APC,[3] LRP5,[6][7] DVL1,[8][7] MAP3K1,[9][10] CSNK1E,[9] Casein kinase 1, alpha 1[9] and PPP2R5A.[11]
References
- ^ Zeng L, Fagotto F, Zhang T, Hsu W, Vasicek TJ, Perry WL 3rd, Lee JJ, Tilghman SM, Gumbiner BM, Costantini F (Aug 1997). "The mouse Fused locus encodes Axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axis formation". Cell 90 (1): 181–92. doi:10.1016/S0092-8674(00)80324-4. PMID 9230313.
- ^ "Entrez Gene: AXIN1 axin 1". http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=8312.
- ^ a b c Nakamura, T; Hamada F, Ishidate T, Anai K, Kawahara K, Toyoshima K, Akiyama T (Jun. 1998). "Axin, an inhibitor of the Wnt signalling pathway, interacts with beta-catenin, GSK-3beta and APC and reduces the beta-catenin level". Genes Cells (ENGLAND) 3 (6): 395–403. doi:10.1046/j.1365-2443.1998.00198.x. ISSN 1356-9597. PMID 9734785.
- ^ Hocevar, B A; Mou F, Rennolds J L, Morris S M, Cooper J A, Howe P H (Jun. 2003). "Regulation of the Wnt signaling pathway by disabled-2 (Dab2)". EMBO J. (England) 22 (12): 3084–94. doi:10.1093/emboj/cdg286. ISSN 0261-4189. PMC 162138. PMID 12805222. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=162138.
- ^ a b Mak, Baldwin C; Takemaru Ken-Ichi, Kenerson Heidi L, Moon Randall T, Yeung Raymond S (Feb. 2003). "The tuberin-hamartin complex negatively regulates beta-catenin signaling activity". J. Biol. Chem. (United States) 278 (8): 5947–51. doi:10.1074/jbc.C200473200. ISSN 0021-9258. PMID 12511557.
- ^ Mao, J; Wang J, Liu B, Pan W, Farr G H, Flynn C, Yuan H, Takada S, Kimelman D, Li L, Wu D (Apr. 2001). "Low-density lipoprotein receptor-related protein-5 binds to Axin and regulates the canonical Wnt signaling pathway". Mol. Cell (United States) 7 (4): 801–9. doi:10.1016/S1097-2765(01)00224-6. ISSN 1097-2765. PMID 11336703.
- ^ a b Kim, Min Jung; Chia Ian V, Costantini Frank (Nov. 2008). "SUMOylation target sites at the C terminus protect Axin from ubiquitination and confer protein stability". FASEB J. (United States) 22 (11): 3785–94. doi:10.1096/fj.08-113910. PMC 2574027. PMID 18632848. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2574027.
- ^ Li, L; Yuan H, Weaver C D, Mao J, Farr G H, Sussman D J, Jonkers J, Kimelman D, Wu D (Aug. 1999). "Axin and Frat1 interact with dvl and GSK, bridging Dvl to GSK in Wnt-mediated regulation of LEF-1". EMBO J. (ENGLAND) 18 (15): 4233–40. doi:10.1093/emboj/18.15.4233. ISSN 0261-4189. PMC 1171499. PMID 10428961. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=1171499.
- ^ a b c Zhang, Yi; Qiu Wen-Jie, Chan Siu Chiu, Han Jiahuai, He Xi, Lin Sheng-Cai (May. 2002). "Casein kinase I and casein kinase II differentially regulate axin function in Wnt and JNK pathways". J. Biol. Chem. (United States) 277 (20): 17706–12. doi:10.1074/jbc.M111982200. ISSN 0021-9258. PMID 11884395.
- ^ Zhang, Y; Neo S Y, Han J, Lin S C (Aug. 2000). "Dimerization choices control the ability of axin and dishevelled to activate c-Jun N-terminal kinase/stress-activated protein kinase". J. Biol. Chem. (UNITED STATES) 275 (32): 25008–14. doi:10.1074/jbc.M002491200. ISSN 0021-9258. PMID 10829020.
- ^ Yamamoto, H; Hinoi T, Michiue T, Fukui A, Usui H, Janssens V, Van Hoof C, Goris J, Asashima M, Kikuchi A (Jul. 2001). "Inhibition of the Wnt signaling pathway by the PR61 subunit of protein phosphatase 2A". J. Biol. Chem. (United States) 276 (29): 26875–82. doi:10.1074/jbc.M100443200. ISSN 0021-9258. PMID 11297546.
Further reading
- Segditsas S, Tomlinson I (2007). "Colorectal cancer and genetic alterations in the Wnt pathway.". Oncogene 25 (57): 7531–7. doi:10.1038/sj.onc.1210059. PMID 17143297.
- Flint J, Thomas K, Micklem G et al. (1997). "The relationship between chromosome structure and function at a human telomeric region". Nat. Genet. 15 (3): 252–7. doi:10.1038/ng0397-252. PMID 9054936.
- Ikeda S, Kishida S, Yamamoto H et al. (1998). "Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin". EMBO J. 17 (5): 1371–84. doi:10.1093/emboj/17.5.1371. PMC 1170485. PMID 9482734. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=1170485.
- Hart MJ, de los Santos R, Albert IN et al. (1998). "Downregulation of beta-catenin by human Axin and its association with the APC tumor suppressor, beta-catenin and GSK3 beta". Curr. Biol. 8 (10): 573–81. doi:10.1016/S0960-9822(98)70226-X. PMID 9601641.
- Nakamura T, Hamada F, Ishidate T et al. (1998). "Axin, an inhibitor of the Wnt signalling pathway, interacts with beta-catenin, GSK-3beta and APC and reduces the beta-catenin level". Genes Cells 3 (6): 395–403. doi:10.1046/j.1365-2443.1998.00198.x. PMID 9734785.
- Hsu W, Zeng L, Costantini F (1999). "Identification of a domain of Axin that binds to the serine/threonine protein phosphatase 2A and a self-binding domain". J. Biol. Chem. 274 (6): 3439–45. doi:10.1074/jbc.274.6.3439. PMID 9920888.
- Kitagawa M, Hatakeyama S, Shirane M et al. (1999). "An F-box protein, FWD1, mediates ubiquitin-dependent proteolysis of beta-catenin". EMBO J. 18 (9): 2401–10. doi:10.1093/emboj/18.9.2401. PMC 1171323. PMID 10228155. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=1171323.
- Fagotto F, Jho E, Zeng L et al. (1999). "Domains of axin involved in protein-protein interactions, Wnt pathway inhibition, and intracellular localization". J. Cell Biol. 145 (4): 741–56. doi:10.1083/jcb.145.4.741. PMC 2133179. PMID 10330403. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2133179.
- Kodama S, Ikeda S, Asahara T et al. (1999). "Axin directly interacts with plakoglobin and regulates its stability". J. Biol. Chem. 274 (39): 27682–8. doi:10.1074/jbc.274.39.27682. PMID 10488109.
- Jho E, Lomvardas S, Costantini F (2000). "A GSK3beta phosphorylation site in axin modulates interaction with beta-catenin and Tcf-mediated gene expression". Biochem. Biophys. Res. Commun. 266 (1): 28–35. doi:10.1006/bbrc.1999.1760. PMID 10581160.
- Ikeda S, Kishida M, Matsuura Y et al. (2000). "GSK-3beta-dependent phosphorylation of adenomatous polyposis coli gene product can be modulated by beta-catenin and protein phosphatase 2A complexed with Axin". Oncogene 19 (4): 537–45. doi:10.1038/sj.onc.1203359. PMID 10698523.
- Satoh S, Daigo Y, Furukawa Y et al. (2000). "AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1". Nat. Genet. 24 (3): 245–50. doi:10.1038/73448. PMID 10700176.
- Spink KE, Polakis P, Weis WI (2000). "Structural basis of the Axin-adenomatous polyposis coli interaction". EMBO J. 19 (10): 2270–9. doi:10.1093/emboj/19.10.2270. PMC 384355. PMID 10811618. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=384355.
- Zhang Y, Neo SY, Han J, Lin SC (2000). "Dimerization choices control the ability of axin and dishevelled to activate c-Jun N-terminal kinase/stress-activated protein kinase". J. Biol. Chem. 275 (32): 25008–14. doi:10.1074/jbc.M002491200. PMID 10829020.
- Daniels RJ, Peden JF, Lloyd C et al. (2001). "Sequence, structure and pathology of the fully annotated terminal 2 Mb of the short arm of human chromosome 16". Hum. Mol. Genet. 10 (4): 339–52. doi:10.1093/hmg/10.4.339. PMID 11157797.
- Yamamoto H, Hinoi T, Michiue T et al. (2001). "Inhibition of the Wnt signaling pathway by the PR61 subunit of protein phosphatase 2A". J. Biol. Chem. 276 (29): 26875–82. doi:10.1074/jbc.M100443200. PMID 11297546.
- Mao J, Wang J, Liu B et al. (2001). "Low-density lipoprotein receptor-related protein-5 binds to Axin and regulates the canonical Wnt signaling pathway". Mol. Cell 7 (4): 801–9. doi:10.1016/S1097-2765(01)00224-6. PMID 11336703.
- Furuhashi M, Yagi K, Yamamoto H et al. (2001). "Axin facilitates Smad3 activation in the transforming growth factor beta signaling pathway". Mol. Cell. Biol. 21 (15): 5132–41. doi:10.1128/MCB.21.15.5132-5141.2001. PMC 87238. PMID 11438668. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=87238.
- Rubinfeld B, Tice DA, Polakis P (2001). "Axin-dependent phosphorylation of the adenomatous polyposis coli protein mediated by casein kinase 1epsilon". J. Biol. Chem. 276 (42): 39037–45. doi:10.1074/jbc.M105148200. PMID 11487578.
PDB gallery
|
|
|
1dk8: CRYSTAL STRUCTURE OF THE RGS-HOMOLOGOUS DOMAIN OF AXIN
|
|
1emu: STRUCTURE OF THE AXIN RGS-HOMOLOGOUS DOMAIN IN COMPLEX WITH A SAMP REPEAT FROM APC
|
|
1wsp: Crystal structure of axin dix domain
|
|
2d5g: Structure of ubiquitin fold protein R767E mutant
|
|
|
|